Clinic
C.L. Anderson, JR., M.D., PLLC
C.L. Anderson, JR., M.D., PLLC was paid $4.71M by Medicaid between Jan 2018 and Dec 2024, across 72 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 23% of everything it billed.
33Billing provider infoC.L. ANDERSON, JR., M.D., PLLC
BROWNSVILLE, TX 78521
BROWNSVILLE, TX 78521
33aNPI1396967659assigned 05/03/2007
33bProvider typeUrgent Care Clinic/Center
28Total paid$4.71M
24GClaims244,530
24DCodes billed72
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Texas
Rank by total paid#9 of 151
Median peer was paid$125K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,452 | $83K | |
| 2019 | 9,188 | $134K | |
| 2020 | 10,706 | $148K | |
| 2021 | 46,875 | $972K | |
| 2022 | 70,019 | $1.49M | |
| 2023 | 61,585 | $1.23M | |
| 2024incomplete | 32,705 | $644K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 33,519 | 29,633 | $1.09M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 19% | 25,117 | 23,055 | $872K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 30,563 | 27,893 | $812K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 11% | 43,952 | 20,594 | $520K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.7% | 7,423 | 7,089 | $363K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5.5% | 21,797 | 20,241 | $259K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4.3% | 5,585 | 5,316 | $201K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 10,843 | 9,889 | $104K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 5,614 | 5,195 | $97K |
| 99444 | 1.6% | 1,396 | 359 | $75K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 1,919 | 1,705 | $62K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,540 | 8,972 | $41K |
60 more codes
| 87807 | <1% | 2,256 | $22K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 909 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,948 | $17K |
| 11721 | <1% | 3,097 | $15K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 217 | $13K |
| 81003 | <1% | 9,417 | $12K | |
| 99051 | <1% | 915 | $12K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,565 | $11K |
| 99441 | <1% | 449 | $9K | |
| 80061 | Lipid panel | <1% | 2,063 | $8K |
| 99421 | <1% | 3,882 | $8K | |
| 80076 | <1% | 2,427 | $7K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,082 | $6K |
| 93000 | <1% | 625 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 730 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 751 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 82 | $4K |
| 73610 | <1% | 157 | $3K | |
| 73562 | <1% | 96 | $3K | |
| 81025 | <1% | 397 | $2K | |
| 72100 | <1% | 92 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,648 | $2K |
| 97169 | <1% | 98 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 36 | $2K |
| 99000 | <1% | 387 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 170 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,764 | $1K |
| 90734 | <1% | 81 | $1K | |
| 73630 | <1% | 51 | $943.47 | |
| 82947 | <1% | 673 | $924.90 | |
| 99384 | <1% | 26 | $902.63 | |
| 90686 | <1% | 158 | $829.18 | |
| 86318 | <1% | 44 | $581.59 | |
| 86580 | <1% | 74 | $501.87 | |
| 99490 | Ccm add 20min | <1% | 427 | $474.69 |
| 0011A | <1% | 18 | $377.45 | |
| 69210 | <1% | 13 | $371.64 | |
| 0012A | <1% | 13 | $360.00 | |
| 74018 | <1% | 14 | $289.56 | |
| 90715 | <1% | 46 | $206.72 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $160.61 |
| 51798 | <1% | 14 | $108.19 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 75 | $25.47 |
| 82948 | <1% | 41 | $23.01 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,894 | $3.00 |
| 91301 | <1% | 55 | $0.01 | |
| 1090F | 0% | 41 | $0.00 | |
| 3288F | 0% | 91 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 108 | $0.00 |
| 90662 | 0% | 39 | $0.00 | |
| 90649 | 0% | 17 | $0.00 | |
| 1170F | 0% | 637 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 15 | $0.00 |
| 1101F | 0% | 14 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 128 | $0.00 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 86 | $0.00 |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | 0% | 25 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 43 | $0.00 |
| 90716 | 0% | 14 | $0.00 | |
| 1036F | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, XAVIER (CEO)